Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia

被引：41
|
作者：
Kolditz, Martin [1 ]
Scherag, Andre [2 ]
Rohde, Gernot [3 ,8 ,9 ,10 ]
Ewig, Santiago [4 ,5 ]
Welte, Tobias [6 ,8 ,9 ,10 ]
Pletz, Mathias [7 ,8 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 1, Div Pulmonol, Fetscherstr 74, D-01307 Dresden, Germany
[2] Jena Univ Hosp, Res Grp Clin Epidemiol, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care, Jena, Germany
[3] Maastricht Univ, Dept Resp Med, Med Ctr, Maastricht, Netherlands
[4] EVK Herne, Dept Resp & Infect Dis, Thoraxzentrum Ruhrgebiet, Bochum, Germany
[5] Augusta Kranken Anstalt Bochum, Bochum, Germany
[6] Hannover Med Sch, Dept Resp Med, Hannover, Germany
[7] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany
[8] CAPNETZ STIFTUNG, Hannover, Germany
[9] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany
[10] German Ctr Lung Res DZL, Hannover, Germany
来源：
INTENSIVE CARE MEDICINE | 2016年 / 42卷 / 12期
关键词：
INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK SEPSIS-3;
D O I：
10.1007/s00134-016-4517-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2108 / 2110
页数：3
相关论文
共 50 条
  • [1] Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia
    Martin Kolditz
    André Scherag
    Gernot Rohde
    Santiago Ewig
    Tobias Welte
    Mathias Pletz
    Intensive Care Medicine, 2016, 42 : 2108 - 2110
  • [2] Validation of the qSOFA(-65) score compared to the CRB-65 score for risk prediction in community-acquired pneumonia
    Kesselmeier, M.
    Pletz, M.
    Scherag, A.
    Bauer, T.
    Ewig, S.
    Kolditz, M.
    PNEUMOLOGIE, 2022, 76 (02): : 119 - 119
  • [3] Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumonia
    Kesselmeier, Miriam
    Pletz, Mathias W.
    Blankenstein, Anna Leona
    Scherag, Andre
    Bauer, Torsten
    Ewig, Santiago
    Kolditz, Martin
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1345.e1 - 1345.e6
  • [4] Comparison Of Risk Prediction With Procalcitonin, Psi, Curb-65 And Crb-65 In Community-Acquired Pneumonia In Singapore
    Zhang, Z. X.
    Li, L.
    Zhang, W.
    Liu, P.
    Yang, Y.
    Tan, W. C.
    Ng, H.
    Fong, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [5] Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumonia
    Richter, Tina
    Tesch, Falko
    Schmitt, Jochen
    Koschel, Dirk
    Kolditz, Martin
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [6] Risk stratification of patients with community-acquired pneumonia using the Pneumonia Severity Index and the CRB-65
    Ott, S. R.
    Pleiss, C.
    INFECTION, 2009, 37 : 17 - 18
  • [7] The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia
    Aliberti, S.
    Brock, G. N.
    Peyrani, P.
    Blasi, F.
    Ramirez, J. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (12) : 1550 - 1556
  • [8] CRB-65 predicts death from community-acquired pneumonia
    Bauer, T. T.
    Ewig, S.
    Marre, R.
    Suttorp, N.
    Welte, T.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (01) : 93 - 101
  • [9] Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
    Dwyer, Richard
    Hedlund, Jonas
    Henriques-Normark, Birgitta
    Kalin, Mats
    BMJ OPEN RESPIRATORY RESEARCH, 2013, 1 (01):
  • [10] Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia
    Farhat, Imrana
    Rosolowski, Maciej
    Ahrens, Katharina
    Lienau, Jasmin
    Ahnert, Peter
    Pletz, Mathias
    Rohde, Gernot
    Rupp, Jan
    Scholz, Markus
    Witzenrath, Martin
    ERJ OPEN RESEARCH, 2024, 10 (06)
12345